Table of Contents 1 Study Coverage 1.1 Quadrivalent Flu Vaccine Product Introduction 1.2 Market Segments 1.3 Key Manufacturers Covered 1.4 Market by Type 1.4.1 Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type 1.4.2 Intramuscular Injection 1.4.3 Nasal Spray 1.4.4 Intradermal Shot 1.5 Market by Application 1.5.1 Global Quadrivalent Flu Vaccine Market Size Growth Rate by Application 1.5.2 Hospital 1.5.3 Clinic 1.5.4 Public Health Agency 1.5.5 Other 1.6 Study Objectives 1.7 Years Considered 2 Executive Summary 2.1 Global Quadrivalent Flu Vaccine Market Size 2.1.1 Global Quadrivalent Flu Vaccine Revenue 2014-2025 2.1.2 Global Quadrivalent Flu Vaccine Sales 2014-2025 2.2 Quadrivalent Flu Vaccine Growth Rate by Regions 2.2.1 Global Quadrivalent Flu Vaccine Sales by Regions 2.2.2 Global Quadrivalent Flu Vaccine Revenue by Regions 3 Breakdown Data by Manufacturers 3.1 Quadrivalent Flu Vaccine Sales by Manufacturers 3.1.1 Quadrivalent Flu Vaccine Sales by Manufacturers 3.1.2 Quadrivalent Flu Vaccine Sales Market Share by Manufacturers 3.2 Quadrivalent Flu Vaccine Revenue by Manufacturers 3.2.1 Quadrivalent Flu Vaccine Revenue by Manufacturers (2014-2019) 3.2.2 Quadrivalent Flu Vaccine Revenue Share by Manufacturers (2014-2019) 3.3 Quadrivalent Flu Vaccine Price by Manufacturers 3.4 Quadrivalent Flu Vaccine Manufacturing Base Distribution, Product Types 3.4.1 Quadrivalent Flu Vaccine Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Quadrivalent Flu Vaccine Product Type 3.4.3 Date of International Manufacturers Enter into Quadrivalent Flu Vaccine Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type 4.1 Global Quadrivalent Flu Vaccine Sales by Type 4.2 Global Quadrivalent Flu Vaccine Revenue by Type 4.3 Quadrivalent Flu Vaccine Price by Type 5 Breakdown Data by Application 5.1 Overview 5.2 Global Quadrivalent Flu Vaccine Breakdown Data by Application 6 North America 6.1 North America Quadrivalent Flu Vaccine by Country 6.1.1 North America Quadrivalent Flu Vaccine Sales by Country 6.1.2 North America Quadrivalent Flu Vaccine Revenue by Country 6.1.3 United States 6.1.4 Canada 6.1.5 Mexico 6.2 North America Quadrivalent Flu Vaccine by Type 6.3 North America Quadrivalent Flu Vaccine by Application 7 Europe 7.1 Europe Quadrivalent Flu Vaccine by Country 7.1.1 Europe Quadrivalent Flu Vaccine Sales by Country 7.1.2 Europe Quadrivalent Flu Vaccine Revenue by Country 7.1.3 Germany 7.1.4 France 7.1.5 UK 7.1.6 Italy 7.1.7 Russia 7.2 Europe Quadrivalent Flu Vaccine by Type 7.3 Europe Quadrivalent Flu Vaccine by Application 8 Asia Pacific 8.1 Asia Pacific Quadrivalent Flu Vaccine by Region 8.1.1 Asia Pacific Quadrivalent Flu Vaccine Sales by Region 8.1.2 Asia Pacific Quadrivalent Flu Vaccine Revenue by Region 8.1.3 China 8.1.4 Japan 8.1.5 South Korea 8.1.6 India 8.1.7 Australia 8.1.8 Indonesia 8.1.9 Thailand 8.1.10 Malaysia 8.1.11 Philippines 8.1.12 Vietnam 8.2 Asia Pacific Quadrivalent Flu Vaccine by Type 8.3 Asia Pacific Quadrivalent Flu Vaccine by Application 9 Central & South America 9.1 Central & South America Quadrivalent Flu Vaccine by Country 9.1.1 Central & South America Quadrivalent Flu Vaccine Sales by Country 9.1.2 Central & South America Quadrivalent Flu Vaccine Revenue by Country 9.1.3 Brazil 9.2 Central & South America Quadrivalent Flu Vaccine by Type 9.3 Central & South America Quadrivalent Flu Vaccine by Application 10 Middle East and Africa 10.1 Middle East and Africa Quadrivalent Flu Vaccine by Country 10.1.1 Middle East and Africa Quadrivalent Flu Vaccine Sales by Country 10.1.2 Middle East and Africa Quadrivalent Flu Vaccine Revenue by Country 10.1.3 Turkey 10.1.4 GCC Countries 10.1.5 Egypt 10.1.6 South Africa 10.2 Middle East and Africa Quadrivalent Flu Vaccine by Type 10.3 Middle East and Africa Quadrivalent Flu Vaccine by Application 11 Company Profiles 11.1 Sanofi Pasteur 11.1.1 Sanofi Pasteur Company Details 11.1.2 Company Business Overview 11.1.3 Sanofi Pasteur Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2014-2019) 11.1.4 Sanofi Pasteur Quadrivalent Flu Vaccine Products Offered 11.1.5 Sanofi Pasteur Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Details 11.2.2 Company Business Overview 11.2.3 AstraZeneca Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2014-2019) 11.2.4 AstraZeneca Quadrivalent Flu Vaccine Products Offered 11.2.5 AstraZeneca Recent Development 11.3 CSL 11.3.1 CSL Company Details 11.3.2 Company Business Overview 11.3.3 CSL Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2014-2019) 11.3.4 CSL Quadrivalent Flu Vaccine Products Offered 11.3.5 CSL Recent Development 11.4 Abbott 11.4.1 Abbott Company Details 11.4.2 Company Business Overview 11.4.3 Abbott Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2014-2019) 11.4.4 Abbott Quadrivalent Flu Vaccine Products Offered 11.4.5 Abbott Recent Development 11.5 GlaxoSmithKline 11.5.1 GlaxoSmithKline Company Details 11.5.2 Company Business Overview 11.5.3 GlaxoSmithKline Quadrivalent Flu Vaccine Sales, Revenue and Gross Margin (2014-2019) 11.5.4 GlaxoSmithKline Quadrivalent Flu Vaccine Products Offered 11.5.5 GlaxoSmithKline Recent Development 12 Future Forecast 12.1 Quadrivalent Flu Vaccine Market Forecast by Regions 12.1.1 Global Quadrivalent Flu Vaccine Sales Forecast by Regions 2019-2025 12.1.2 Global Quadrivalent Flu Vaccine Revenue Forecast by Regions 2019-2025 12.2 Quadrivalent Flu Vaccine Market Forecast by Type 12.2.1 Global Quadrivalent Flu Vaccine Sales Forecast by Type 2019-2025 12.2.2 Global Quadrivalent Flu Vaccine Revenue Forecast by Type 2019-2025 12.3 Quadrivalent Flu Vaccine Market Forecast by Application 12.4 North America Quadrivalent Flu Vaccine Forecast 12.5 Europe Quadrivalent Flu Vaccine Forecast 12.6 Asia Pacific Quadrivalent Flu Vaccine Forecast 12.7 Central & South America Quadrivalent Flu Vaccine Forecast 12.8 Middle East and Africa Quadrivalent Flu Vaccine Forecast 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Market Opportunities and Drivers 13.2 Market Challenges 13.3 Market Risks/Restraints 13.4 Macroscopic Indicators 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Quadrivalent Flu Vaccine Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables and Figures Figure Quadrivalent Flu Vaccine Product Picture Table Quadrivalent Flu Vaccine Market Segments Table Key Manufacturers Quadrivalent Flu Vaccine Covered Table Global Quadrivalent Flu Vaccine Market Size Growth Rate by Type 2019-2025 (K Doses) & (Million US$) Figure Global Quadrivalent Flu Vaccine Sales Market Share by Type in 2018 & 2025 Figure Intramuscular Injection Product Picture Table Major Manufacturers of Intramuscular Injection Figure Nasal Spray Product Picture Table Major Manufacturers of Nasal Spray Figure Intradermal Shot Product Picture Table Major Manufacturers of Intradermal Shot Table Global Quadrivalent Flu Vaccine Market Size Growth Rate by Application 2019-2025 (K Doses) Figure Global Quadrivalent Flu Vaccine 4900 Sales Market Share by Application in 2018 Figure Hospital Figure Clinic Figure Public Health Agency Figure Other Figure Quadrivalent Flu Vaccine Report Years Considered Figure Global Quadrivalent Flu Vaccine Market Size 2014-2025 (Million US$) Figure Global Quadrivalent Flu Vaccine Sales 2014-2025 (K Doses) Table Global Quadrivalent Flu Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$) Table Global Quadrivalent Flu Vaccine Sales by Regions 2014-2019 (K Doses) Table Global Quadrivalent Flu Vaccine Sales Market Share by Regions 2014-2019 Figure Global Quadrivalent Flu Vaccine Sales Market Share by Regions 2014-2019 Figure 2018 Global Quadrivalent Flu Vaccine Sales Market Share by Regions Table Global Quadrivalent Flu Vaccine Revenue by Regions 2014-2019 (Million US$) Table Global Quadrivalent Flu Vaccine Revenue Market Share by Regions 2014-2019 Figure Global Quadrivalent Flu Vaccine Revenue Market Share by Regions 2014-2019 Figure 2018 Global Quadrivalent Flu Vaccine Revenue Market Share by Regions Table Global Quadrivalent Flu Vaccine Sales by Manufacturers (2014-2019) (K Doses) Table Global Quadrivalent Flu Vaccine Sales Share by Manufacturers (2014-2019) Figure Global Quadrivalent Flu Vaccine Sales Share by Manufacturers in 2018 Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Quadrivalent Flu Vaccine Revenue by Manufacturers (2014-2019) (Million USD) Table Quadrivalent Flu Vaccine Revenue Share by Manufacturers (2014-2019) Figure Quadrivalent Flu Vaccine Value Share by Manufacturers in 2018 Table Key Manufacturers Quadrivalent Flu Vaccine Price (2014-2019) (USD/Dose) Table Quadrivalent Flu Vaccine Manufacturers Manufacturing Base Distribution and Headquarters Table Manufacturers Quadrivalent Flu Vaccine Product Type Table Date of International Manufacturers Enter into Quadrivalent Flu Vaccine Market Table Manufacturers Mergers & Acquisitions, Expansion Plans Table Global Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses) Table Global Quadrivalent Flu Vaccine Sales Share by Type (2014-2019) Figure Global Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019) Figure Global Quadrivalent Flu Vaccine Sales Market Share by Type in 2018 Table Global Quadrivalent Flu Vaccine Revenue by Type (2014-2019) (Million US$) Table Global Quadrivalent Flu Vaccine Revenue Share by Type (2014-2019) Figure Global Quadrivalent Flu Vaccine Revenue Market Share by Type (2014-2019) Figure Global Quadrivalent Flu Vaccine Revenue Market Share by Type in 2018 Table Quadrivalent Flu Vaccine Price by Type 2014-2019 (USD/Dose) Table Global Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses) Table Global Quadrivalent Flu Vaccine Sales Share by Application (2014-2019) Figure Global Sales Quadrivalent Flu Vaccine Market Share by Application (2014-2019) Figure Global Sales Quadrivalent Flu Vaccine Market Share by Application in 2018 Figure North America Quadrivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses) Figure North America Quadrivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table North America Quadrivalent Flu Vaccine Sales by Country (2014-2019) (K Doses) Table North America Quadrivalent Flu Vaccine Sales Market Share by Country (2014-2019) Figure 2018 North America Quadrivalent Flu Vaccine Sales Market Share by Country Table North America Quadrivalent Flu Vaccine Revenue by Country (2014-2019) (Million US$) Table North America Quadrivalent Flu Vaccine Revenue Market Share by Country (2014-2019) Figure 2018 North America Quadrivalent Flu Vaccine Revenue Market Share by Country Figure United States Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure United States Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Canada Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Canada Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Mexico Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Mexico Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Table North America Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses) Table North America Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019) Figure 2018 North America Quadrivalent Flu Vaccine Market Share by Type Table North America Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses) Table North America Quadrivalent Flu Vaccine Sales Market Share by Application (2014-2019) Figure 2018 North America Quadrivalent Flu Vaccine Market Share by Application Figure Europe Quadrivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses) Figure Europe Quadrivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table Europe Quadrivalent Flu Vaccine Sales by Country (2014-2019) (K Doses) Table Europe Quadrivalent Flu Vaccine Sales Market Share by Country (2014-2019) Figure 2018 Europe Quadrivalent Flu Vaccine Sales Market Share by Country Table Europe Quadrivalent Flu Vaccine Revenue by Country (2014-2019) (Million US$) Table Europe Quadrivalent Flu Vaccine Revenue Market Share by Country (2014-2019) Figure 2018 Europe Quadrivalent Flu Vaccine Revenue Market Share by Country Figure Germany Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Germany Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure France Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure France Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure UK Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure UK Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Italy Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Italy Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Russia Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Russia Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Table Europe Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses) Table Europe Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019) Figure 2018 Europe Quadrivalent Flu Vaccine Market Share by Type Table Europe Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses) Table Europe Quadrivalent Flu Vaccine Sales Market Share by Application (2014-2019) Figure 2018 Europe Quadrivalent Flu Vaccine Market Share by Application Figure Asia Pacific Quadrivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses) Figure Asia Pacific Quadrivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table Asia Pacific Quadrivalent Flu Vaccine Sales by Region (2014-2019) (K Doses) Table Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Region (2014-2019) Figure 2018 Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Region Table Asia Pacific Quadrivalent Flu Vaccine Revenue by Region (2014-2019) (Million US$) Table Asia Pacific Quadrivalent Flu Vaccine Revenue Market Share by Region (2014-2019) Figure 2018 Asia Pacific Quadrivalent Flu Vaccine Revenue Market Share by Country Figure China Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure China Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Japan Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Japan Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure South Korea Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure South Korea Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure India Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure India Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Australia Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Australia Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Indonesia Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Indonesia Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Thailand Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Thailand Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Malaysia Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Malaysia Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Philippines Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Philippines Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Vietnam Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Vietnam Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Table Asia Pacific Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses) Table Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019) Figure 2018 Asia Pacific Quadrivalent Flu Vaccine Market Share by Type Table Asia Pacific Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses) Table Asia Pacific Quadrivalent Flu Vaccine Sales Market Share by Application (2014-2019) Figure 2018 Asia Pacific Quadrivalent Flu Vaccine Market Share by Application Figure Central & South America Quadrivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses) Figure Central & South America Quadrivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table Central & South America Quadrivalent Flu Vaccine Sales by Country (2014-2019) (K Doses) Table Central & South America Quadrivalent Flu Vaccine Sales Market Share by Country (2014-2019) Figure 2018 Central & South America Quadrivalent Flu Vaccine Sales Market Share by Country Table Central & South America Quadrivalent Flu Vaccine Revenue by Country (2014-2019) (Million US$) Table Central & South America Quadrivalent Flu Vaccine Revenue Market Share by Country (2014-2019) Figure 2018 Central & South America Quadrivalent Flu Vaccine Revenue Market Share by Country Figure Brazil Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Brazil Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Table Central & South America Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses) Table Central & South America Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019) Figure 2018 Central & South America Quadrivalent Flu Vaccine Market Share by Type Table Central & South America Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses) Table Central & South America Quadrivalent Flu Vaccine Sales Market Share by Application (2014-2019) Figure 2018 Central & South America Quadrivalent Flu Vaccine Market Share by Application Figure Middle East and Africa Quadrivalent Flu Vaccine Sales Growth Rate 2014-2019 (K Doses) Figure Middle East and Africa Quadrivalent Flu Vaccine Revenue Growth Rate 2014-2019 (Million US$) Table Middle East and Africa Quadrivalent Flu Vaccine Sales by Country (2014-2019) (K Doses) Table Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Country (2014-2019) Figure 2018 Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Country Table Middle East and Africa Quadrivalent Flu Vaccine Revenue by Country (2014-2019) (Million US$) Table Middle East and Africa Quadrivalent Flu Vaccine Revenue Market Share by Country (2014-2019) Figure 2018 Middle East and Africa Quadrivalent Flu Vaccine Revenue Market Share by Country Figure Turkey Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Turkey Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure GCC Countries Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure GCC Countries Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure Egypt Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure Egypt Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Figure South Africa Quadrivalent Flu Vaccine Sales Growth Rate (2014-2019) (K Doses) Figure South Africa Quadrivalent Flu Vaccine Revenue Growth Rate (2014-2019) (Million US$) Table Middle East and Africa Quadrivalent Flu Vaccine Sales by Type (2014-2019) (K Doses) Table Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Type (2014-2019) Figure 2018 Middle East and Africa Quadrivalent Flu Vaccine Market Share by Type Table Middle East and Africa Quadrivalent Flu Vaccine Sales by Application (2014-2019) (K Doses) Table Middle East and Africa Quadrivalent Flu Vaccine Sales Market Share by Application (2014-2019) Figure 2018 Middle East and Africa Quadrivalent Flu Vaccine Market Share by Application Table Sanofi Pasteur Company Details Table Sanofi Pasteur Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Sanofi Pasteur Recent Development Table AstraZeneca Company Details Table AstraZeneca Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table AstraZeneca Recent Development Table CSL Company Details Table CSL Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table CSL Recent Development Table Abbott Company Details Table Abbott Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table Abbott Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Quadrivalent Flu Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019) Table GlaxoSmithKline Recent Development Table Global Quadrivalent Flu Vaccine Sales Forecast by Regions 2019-2025 (K Doses) Table Global Quadrivalent Flu Vaccine Sales Market Share Forecast by Regions 2019-2025 Table Global Quadrivalent Flu Vaccine Revenue Forecast by Regions 2019-2025 (Million US$) Table Global Quadrivalent Flu Vaccine Revenue Market Share Forecast by Regions 2019-2025 Table Global Quadrivalent Flu Vaccine Sales Forecast by Type 2019-2025 (K Doses) Table Global Quadrivalent Flu Vaccine Sales Market Share Forecast by Type 2019-2025 Table Global Quadrivalent Flu Vaccine Revenue Forecast by Type 2019-2025 (Million US$) Table Global Quadrivalent Flu Vaccine Revenue Market Share Forecast by Type 2019-2025 Table Global Quadrivalent Flu Vaccine Sales Forecast by Application 2019-2025 (K Doses) Table Global Quadrivalent Flu Vaccine Sales Market Share Forecast by Application 2019-2025 Figure North America Quadrivalent Flu Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses) Figure North America Quadrivalent Flu Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Europe Quadrivalent Flu Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses) Figure Europe Quadrivalent Flu Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Asia Pacific Quadrivalent Flu Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses) Figure Asia Pacific Quadrivalent Flu Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Central & South America Quadrivalent Flu Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses) Figure Central & South America Quadrivalent Flu Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$) Figure Middle East and Africa Quadrivalent Flu Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses) Figure Middle East and Africa Quadrivalent Flu Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$) Table Key Opportunities and Drivers: Impact Analysis (2019-2025) Table Key Challenges Table Market Risks Figure Porter's Five Forces Analysis Table Quadrivalent Flu Vaccine Value Chain Table Quadrivalent Flu Vaccine Customers List Figure Channels of Distribution Table Quadrivalent Flu Vaccine Distributors List Figure Distributors Profiles Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Figure Key Executives Interviewed Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Sanofi Pasteur AstraZeneca CSL Abbott GlaxoSmithKline